Press release
MrMed Joins the Google Play Accelerator India 2026 Cohort
We are happy to announce that MrMed has been selected for the Google Play Accelerator India 2026 Cohort, alongside 20 other AI-driven startups driving breakthrough innovations in India. This equity-free program lasts three months and allows selected startups to work with Google Play's product team and benefit from its wide portfolio of technologies across areas such as AI, security, and monetization.MrMed has been chosen as a nominee for the Google Play Accelerator, which allows us to apply even better AI technologies in the area we have been engaged with for the last five years: linking patients to the necessary treatments and medications when they need them.
As part of this group, MrMed will collaborate with Google's product specialists to improve AI for the patient experience, enabling caregivers to access accurate medical information and assisting patients undergoing long-term treatment with placing repeat orders. The training, along with access to Google's technological capabilities, is expected to help improve MrMed's user-friendly platform in the coming months.
With the help of this program, MrMed will focus on enhancing the artificial intelligence that enables it to meet customer requests and on developing a better approach to the ordering cycle, helping patients more easily manage long-term medical care.
MrMed participated in a group spanning health care, education, agriculture, and finance, focused on creating AI-based products for the Indian economy, demonstrating AI's impact in resolving complex issues. This is another achievement after MrMed was awarded the Healthcare Start-Up of the Year by FICCI in 2022. What is more important is that the appearance of MrMed among the members of this group is promising for the field of healthcare in India.
Thus, although MrMed is moving forward, the company continues to focus on developing products that deliver real benefits to patients and their families. At the same time, technological innovations never prevent patients from receiving care.
Company: MrMed.in
Website: https://www.mrmed.in/
Address: No. 5 (3), Ground Floor, Raja Street, T-Nagar, Chennai - 600017 (India)
Phone: +91-8939169999
Email: support@mrmed.in
MrMed is India's largest online specialty pharmacy, dedicated to making high-cost medicines accessible and affordable. The company provides genuine products, specialist counseling, and reliable cold-chain delivery to patients across therapeutic areas nationwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MrMed Joins the Google Play Accelerator India 2026 Cohort here
News-ID: 4610974 • Views: …
More Releases from MrMed.in
MrMed Pledges 1,000 Volunteering Hours for Caregivers
MrMed, which provides medicines for special diseases, has launched an initiative named "Care for the Caregiver" that provides support for the caregivers of patients suffering from critical illnesses such as cancer, rare diseases, and post-transplant care. The initiative was launched on the company's Impact Day, celebrated every year on June 26 in memory of Mrs Divya Jain, who served as the Administrative Head of MrMed and was also the wife…
MrMed Pharmacy Expands to Guwahati, Making Speciality and Life-Saving Medicines …
MrMed, one of India's most trusted platforms to buy medicine online, announces the opening of its new Distribution Hub in Guwahati, Assam. The expansion brings affordable speciality medicines in North East India closer to patients who have long struggled to access critical treatments locally.
MrMed Comes to Guwahati
The new MrMed Guwahati Distribution Hub directly addresses the gap in speciality medicine delivery in North East India. Patients managing cancer, rare diseases, and…
MrMed Partners with Eli Lilly to Expand Access to Affordable GLP-1 Medications i …
MrMed, India's leading online specialty pharmacy, has announced a strategic partnership with global pharmaceutical leader Eli Lilly. This collaboration aims to improve access to affordable GLP-1 medications for India's growing diabetes and obesity population.
India faces a severe healthcare crisis with over 100 million people affected by diabetes and obesity. Rising treatment costs force families to exhaust savings and borrow at high rates. Many advanced therapies remain financially out of reach…
MrMed Opens Bengaluru Hub to Expand Access to Critical Medicines Across South In …
MrMed, India's leading online super-speciality pharmacy, marked a major milestone with the opening of its third hub in Bengaluru, following Chennai and Delhi. This strategic expansion not only strengthens MrMed's national footprint but also enables faster, more reliable access to speciality medicines, cancer treatments, and life-saving drugs for patients across Karnataka and neighbouring states.
Scaling Innovation Through Expansion
Founded by Devashish Singh and Saurab Jain, MrMed is transforming how patients access critical…
More Releases for MrMed
MrMed Pledges 1,000 Volunteering Hours for Caregivers
MrMed, which provides medicines for special diseases, has launched an initiative named "Care for the Caregiver" that provides support for the caregivers of patients suffering from critical illnesses such as cancer, rare diseases, and post-transplant care. The initiative was launched on the company's Impact Day, celebrated every year on June 26 in memory of Mrs Divya Jain, who served as the Administrative Head of MrMed and was also the wife…
MrMed Pharmacy Expands to Guwahati, Making Speciality and Life-Saving Medicines …
MrMed, one of India's most trusted platforms to buy medicine online, announces the opening of its new Distribution Hub in Guwahati, Assam. The expansion brings affordable speciality medicines in North East India closer to patients who have long struggled to access critical treatments locally.
MrMed Comes to Guwahati
The new MrMed Guwahati Distribution Hub directly addresses the gap in speciality medicine delivery in North East India. Patients managing cancer, rare diseases, and…
MrMed Partners with Eli Lilly to Expand Access to Affordable GLP-1 Medications i …
MrMed, India's leading online specialty pharmacy, has announced a strategic partnership with global pharmaceutical leader Eli Lilly. This collaboration aims to improve access to affordable GLP-1 medications for India's growing diabetes and obesity population.
India faces a severe healthcare crisis with over 100 million people affected by diabetes and obesity. Rising treatment costs force families to exhaust savings and borrow at high rates. Many advanced therapies remain financially out of reach…
MrMed Opens Bengaluru Hub to Expand Access to Critical Medicines Across South In …
MrMed, India's leading online super-speciality pharmacy, marked a major milestone with the opening of its third hub in Bengaluru, following Chennai and Delhi. This strategic expansion not only strengthens MrMed's national footprint but also enables faster, more reliable access to speciality medicines, cancer treatments, and life-saving drugs for patients across Karnataka and neighbouring states.
Scaling Innovation Through Expansion
Founded by Devashish Singh and Saurab Jain, MrMed is transforming how patients access critical…
Redefining Accessibility: How Pharma Companies Like MrMed Are Making Speciality …
In India, where healthcare access has traditionally been unequal, the rising cost of medicines and medical services has created significant challenges for people suffering from serious conditions like cancer, heart disease, and kidney disorders. However, healthcare companies in the country are stepping up to make care more affordable and accessible. One standout example is MrMed, an online pharmacy that specialises in super-speciality medicines and offers life-saving treatments at much lower…
MrMed Achieves Record Growth with 50% Revenue Surge in FY24!
MrMed, India's leading online platform for speciality medicines, announced its remarkable financial achievements for the fiscal year 2024 (FY24). These achievements underscore the company's commitment to making healthcare more accessible and affordable across the country. The company successfully reduced its overall losses by 31%, bringing them down to ₹1.5 crore, a significant improvement from the previous fiscal year.
The company reported a 50% increase in revenue, reaching ₹24 crores for FY24,…
